Crossmark

Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma

Crossref DOI link: https://doi.org/10.1136/jitc-2021-002882

Published Online: 2021-07-15

Published Print: 2021-07

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Leko, Vid https://orcid.org/0000-0001-7883-5030
Cafri, Gal

Yossef, Rami

Paria, Biman

Hill, Victoria

Gurusamy, Devikala

Zheng, Zhili

Gartner, Jared J

Prickett, Todd D

Goff, Stephanie L https://orcid.org/0000-0003-3317-9804
Robbins, Paul https://orcid.org/0000-0002-1260-8123
Lu, Yong-Chen

Rosenberg, Steven A
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct01454596 at ClinicalTrials.gov

Documents that mention this clinical trial

Identification of neoantigen-reactive T lymphocytes in the peripheral blood of a patient with glioblastoma
https://doi.org/10.1136/jitc-2021-002882

Advances in the management of glioblastoma
https://doi.org/10.1136/jnnp-2020-325334

Co-evolution of glioma and immune microenvironment
https://doi.org/10.1136/jitc-2024-009175

Chimeric antigen receptor (CAR) T-cell therapy for glioblastoma (GBM): current clinical insights, challenges, and future directions
https://doi.org/10.1136/jitc-2025-012308
Funding

Funding for this research was provided by:

National Cancer Institute
License Information

License valid from 2021-07-15